Ishak Emily, Burg Emily A, Pike James Russell, Amezcua Pablo Martinez, Jiang Kening, Powell Danielle S, Huang Alison R, Suen Jonathan J, Lutsey Pamela L, Sharrett A Richey, Coresh Josef, Reed Nicholas S, Deal Jennifer A, Smith Jason R
Columbia University Irving Medical Center, New York, New York.
Vanderbilt Bill Wilkerson Center for Otolaryngology and Communication Sciences, Vanderbilt University Medical Center, Nashville, Tennessee.
JAMA Otolaryngol Head Neck Surg. 2025 Apr 17. doi: 10.1001/jamaoto.2025.0192.
Hearing loss treatment delays cognitive decline in high-risk older adults. The preventive potential of addressing hearing loss on incident dementia in a community-based population of older adults, and whether it varies by method of hearing loss measurement, is unknown.
To calculate the population attributable fraction of incident dementia associated with hearing loss in older adults and to investigate differences by age, sex, self-reported race, and method of hearing loss measurement.
DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study was part of the Atherosclerosis Risk in Communities Neurocognitive Study (ARIC-NCS) and had up to 8 years of follow-up (2011-2019). The 4 ARIC field centers in the study included Jackson, Mississippi; Forsyth County, North Carolina; the Minneapolis suburbs, Minnesota; and Washington County, Maryland. Community-dwelling older adults aged 66 to 90 years without dementia at baseline who underwent a hearing assessment at ARIC-NCS visit 6 (2016-2017) were included in the analysis. Data analysis took place between June 2022 and July 2024.
Hearing loss measured objectively (audiometric) and subjectively (self-reported).
The main outcome was incident dementia (standardized algorithmic diagnosis with expert panel review). The population attributable fractions of dementia from both audiometric and self-reported hearing loss were calculated in the same participants, which quantified the maximum proportion of dementia risk in the population that can be attributed to hearing loss.
Among 2946 participants (mean [SD] age, 74.9 [4.6] years; 1751 [59.4] female; 637 Black [21.6%] and 2309 White [78.4%] individuals), 1947 participants (66.1%) had audiometric hearing loss, and 1097 (37.2%) had self-reported hearing loss. The population attributable fraction of dementia from any audiometric hearing loss was 32.0% (95% CI, 11.0%-46.5%). Population attributable fractions were similar by hearing loss severity (mild HL: 16.2% [95% CI, 4.2%-24.2%]; moderate or greater HL: 16.6% [95% CI, 3.9%-24.3%]). Self-reported hearing loss was not associated with an increased risk for dementia, so the population attributable fraction was not quantifiable. Population attributable fractions from audiometric hearing loss were larger among those who were 75 years and older (30.5% [95% CI, -5.8% to 53.1%]), female (30.8% [95% CI, 5.9%-47.1%]), and White (27.8% [95% CI, -6.0% to 49.8%]), relative to those who were younger than 75 years, male, and Black.
This cohort study suggests that treating hearing loss might delay dementia for a large number of older adults. Public health interventions targeting clinically significant audiometric hearing loss might have broad benefits for dementia prevention. Future research quantifying population attributable fractions should carefully consider which measures are used to define hearing loss, as self-reporting may underestimate hearing-associated dementia risk.
听力损失治疗可延缓高危老年人的认知衰退。在社区老年人群中,解决听力损失对预防新发痴呆症的潜在作用,以及其是否因听力损失测量方法而异,目前尚不清楚。
计算老年人中与听力损失相关的新发痴呆症的人群归因分数,并按年龄、性别、自我报告的种族和听力损失测量方法进行差异调查。
设计、设置和参与者:这项前瞻性队列研究是社区动脉粥样硬化风险神经认知研究(ARIC-NCS)的一部分,随访时间长达8年(2011 - 2019年)。该研究中的4个ARIC现场中心包括密西西比州的杰克逊;北卡罗来纳州的福赛斯县;明尼苏达州明尼阿波利斯郊区;以及马里兰州的华盛顿县。分析纳入了在基线时无痴呆症、在ARIC-NCS第6次访视(2016 - 2017年)时接受听力评估的66至90岁社区居住老年人。数据分析于2022年6月至2024年7月进行。
客观测量(听力测定)和主观测量(自我报告)的听力损失。
主要结局是新发痴呆症(经专家小组审查的标准化算法诊断)。在同一参与者中计算听力测定和自我报告的听力损失导致的痴呆症的人群归因分数,该分数量化了人群中可归因于听力损失的痴呆症风险的最大比例。
在2946名参与者中(平均[标准差]年龄为74.9[4.6]岁;1751名[59.4%]为女性;637名黑人[21.6%]和2309名白人[78.4%]),1947名参与者(66.1%)有听力测定的听力损失,1097名(37.2%)有自我报告的听力损失。任何听力测定的听力损失导致的痴呆症的人群归因分数为32.0%(95%置信区间,11.0% - 46.5%)。按听力损失严重程度划分的人群归因分数相似(轻度听力损失:16.2%[95%置信区间,4.2% - 24.2%];中度或更严重听力损失:16.6%[95%置信区间,3.9% - 24.3%])。自我报告的听力损失与痴呆症风险增加无关,因此人群归因分数无法量化。相对于75岁以下、男性和黑人,75岁及以上者(30.5%[95%置信区间, - 5.8%至53.1%])、女性(30.8%[95%置信区间,5.9% - 47.1%])和白人(27.8%[95%置信区间, - 6.0%至49.8%])因听力测定的听力损失导致的人群归因分数更大。
这项队列研究表明,治疗听力损失可能会延缓大量老年人的痴呆症发生。针对具有临床意义的听力测定听力损失的公共卫生干预措施可能对预防痴呆症有广泛益处。未来量化人群归因分数的研究应仔细考虑使用哪些测量方法来定义听力损失,因为自我报告可能会低估与听力相关的痴呆症风险。